Difference between revisions of "Fibronectin (TG2)"
m |
|||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | | + | | align="center" colspan="2" bgcolor="#ffffff" | |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Fibronectin |
|- | |- | ||
| Synonyms | | Synonyms | ||
| Line 17: | Line 17: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | Extracellular matrix | + | | Extracellular matrix |
| + | Plasma | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| Line 38: | Line 39: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 50: | Line 51: | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:37, 10 March 2015
| Fibronectin (TG2) | |
|---|---|
| Substrate peptide name | Fibronectin |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Extracellular matrix
Plasma |
| Swissprot ID | P02751 |
| Reactive glutamines | Q3, Q32 |
| Reactive lysines | Not determined yet |
| Substrate sequence | EAQQIVQP
HYQINQQWERT |
| Structure | 1O6A |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:2867902 |
| Notes | There are four Q substrate residues in intact fibronectin, while in cleaved form there are eight-nine Q substrate residues |
